Lords Mark Industries Establishes New IVD Manufacturing Facility in Vasai; Total Footprint Increases to 34,000 Sq. Ft.

Lords Mark Industries Establishes New IVD Manufacturing Facility in Vasai; Total Footprint Increases to 34,000 Sq. Ft.​

Lords Mark Industries Limited, formerly known as Lords Mark India Limited and Kratos Energy & Infrastructure Limited, has significantly expanded its operational capacity by establishing a new state-of-the-art In Vitro Diagnostics (IVD) manufacturing facility in Vasai (East), Maharashtra. The launch of this new unit marks a major stride for the company in strengthening its production capabilities within the diagnostics sector.

The new facility, which measures approximately 14,000 sq. ft., became operational two months ahead of the August 2026 schedule. This expansion has increased the Company's total manufacturing footprint from 20,000 sq. ft. to 34,000 sq. ft.

The newly commissioned unit is equipped to manufacture a portfolio that includes 56 ELISA test kits alongside an expanded range of rapid diagnostic test kits. This enhanced capacity is set to improve operational efficiency and support growing market demands for quality diagnostics.

Strategic Growth and Future Ambitions​

Beyond the immediate expansion, Lords Mark Industries has dedicated its research division at this facility to the memory of Late Shri Ratan Tata. This unit will focus on indigenous molecular biology research and genetic science initiatives aimed at strengthening domestic scientific capabilities.

Looking ahead, the company is committed to long-term growth in the medical device sector. Plans include establishing a third major facility in Vasai, Maharashtra, which will be dedicated to early cancer detection. This future center will be named in honour of Late Dr. A.P.J. Abdul Kalam and is scheduled to commence operations from January 2029.

The company has articulated an overarching vision to become one of the world's largest medical device manufacturing facilities in India, concentrating on AI-enabled and imaging-based diagnostic devices.

Management Commentary​

Mr. Sachidanand Upadhyay, Managing Director of the Company, commented on these developments, stating that every milestone is guided by the conviction that world-class healthcare must be built within India for both Indian citizens and the global community. He emphasized the commitment to indigenous science and earlier cancer detection, noting that the company has the resources necessary to become a partner in wellness globally.

Stock Price Movement​

Lords Mark Industries Ltd shares settled at ₹669.70 on Thursday, rising 4.99% from its previous close.
The stock remained completely flat throughout the trading session, with its intraday range being locked precisely at this price point.